Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pain, Postoperative 31Breast Neoplasms 24Agnosia 11Pain 10Lung Neoplasms 10Leiomyoma 7Pancreatic Neoplasms 5Neoplasms 5Prostatic Neoplasms 4Rectal Neoplasms 3Neuroma 3Neuralgia 3Hot Flashes 3Colorectal Neoplasms 3Colonic Neoplasms 3Thyroid Nodule 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphedema 2Liver Neoplasms 2Kidney Neoplasms 2Ileus 2Hyperparathyroidism 2Goiter 2Digestive System Diseases 2Chronic Pain 2Breast Cancer Female 2Brain Neoplasms 2Adenomyosis 2Abdominal Cancer 2

Interventions

Paclitaxel 13pembrolizumab 8Carboplatin 7Cisplatin 5Docetaxel 4Brachytherapy 4Pemetrexed 3Gemcitabine 3Doxorubicin 3Biopsy 3osimertinib 2olaparib 2niraparib 2durvalumab 2adavosertib 2Trastuzumab 2Topotecan 2Taxes 2Standard of Care 2Sentinel Lymph Node Biopsy 2Saline Solution 2Radiotherapy 2Radiation 2Oxaliplatin 2Nivolumab 2Music Therapy 2Magnetic Resonance Spectroscopy 2Leucovorin 2Letrozole 2Immunoglobulin G 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Neoplasms × Bupivacaine × Clear all
NCT04849858 2024-08-23

Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures

University of California, Irvine

Phase 3 Terminated
13 enrolled
Gynecologic

Leiomyoma, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡